Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

345
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
345
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

314
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
314
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

545
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
545
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

1.4K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

508
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
508
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

330
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
330

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[The interdisciplinary approach as tool of pharmaceutical education of children: from theory to practice].

Problemy sotsial'noi gigieny, zdravookhraneniia i istorii meditsiny·2024
Same author

[NORMATIVE AND LEGAL ASPECTS OF THE FORMATION OF THE BASIC PREREQUISITES OF PUBLIC HEALTH (PUBLICATIONS REVIEW)].

Problemy sotsial'noi gigieny, zdravookhraneniia i istorii meditsiny·2022
Same author

[The methodology of controllable medical pharmaceutical monitoring of patients: from theory to practice (publications review)].

Problemy sotsial'noi gigieny, zdravookhraneniia i istorii meditsiny·2021
Same author

[THE AWARENESS OF MEDICAL PROFESSIONALS OF ISSUES OF STORAGE AND DESTRUCTION OF PHARMACEUTICALS].

Problemy sotsial'noi gigieny, zdravookhraneniia i istorii meditsiny·2019
Same author

[PROSPECTS OF INFORMATION INTERACTION OF MEDICAL AND PHARMACEUTICAL SPECIALISTS IN ASSISTING GERIATRIC PATIENTS].

Advances in gerontology = Uspekhi gerontologii·2015
Same author

[Analysis of effects of pharmacotherapy on certain parameters of clinical laboratory diagnostics].

Klinicheskaia meditsina·2015

Related Experiment Video

Updated: Mar 24, 2026

Exploring the Two Herb Combination Strategy to Treat Injured PC12 Cells
10:33

Exploring the Two Herb Combination Strategy to Treat Injured PC12 Cells

Published on: November 18, 2022

1.8K

[RATIONAL COMBINATION OF MEDICATIONS FOR THE TREATMENT OF VASCULAR PATHOLOGY IN GERIATRICS].

S E Kozlov, I A Kirshchina, Yu S Gabdrafikova

    Klinicheskaia Meditsina
    |March 19, 2016
    PubMed
    Summary

    This study analyzed drug interactions in elderly women with vascular conditions. It identified polypharmacy as common and aimed to find safer medication combinations for long-term treatment.

    More Related Videos

    Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
    13:48

    Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound

    Published on: April 21, 2023

    2.1K

    Related Experiment Videos

    Last Updated: Mar 24, 2026

    Exploring the Two Herb Combination Strategy to Treat Injured PC12 Cells
    10:33

    Exploring the Two Herb Combination Strategy to Treat Injured PC12 Cells

    Published on: November 18, 2022

    1.8K
    Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
    13:48

    Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound

    Published on: April 21, 2023

    2.1K

    Area of Science:

    • Geriatric Medicine
    • Clinical Pharmacology
    • Cardiovascular Medicine

    Context:

    • Elderly patients with multiple vascular conditions (hypertension, coronary heart disease, atherosclerosis) often receive complex medication regimens.
    • Polypharmacy (concurrent use of 4-6+ medications) is prevalent in this demographic.
    • Drug interactions (Type A reactions) pose a significant risk in managing chronic vascular diseases.

    Purpose:

    • To retrospectively analyze drug combinations used for long-term treatment of comorbid vascular pathology in elderly women.
    • To evaluate the probability and characteristics of drug interactions within prescribed medication combinations.
    • To identify optimal and safer drug combinations for managing vascular co-morbidity in the elderly.

    Summary:

    • Retrospective analysis of medication regimens in elderly women (mean age 73) with arterial hypertension, coronary heart disease, and vascular atherosclerosis.
    • Identified polypharmacy (56.7% on 4-5 drugs, 43.3% on 6+ drugs) as a key characteristic.
    • Examined drug interactions (Type A reactions) against national and WHO classifications, distinguishing nine common combinations.

    Impact:

    • Highlights the significant issue of polypharmacy in elderly patients with vascular co-morbidity.
    • Provides insights into drug interaction risks associated with common medication combinations.
    • Aims to inform the development of safer, evidence-based pharmacotherapy strategies for this vulnerable population.